Virtus ETF Advisers LLC
- SEC CIK
- 0001587281
- Latest filing
- Aug 11, 2026
PCVX holding history
Vaxcyte, Inc. in every 13F filed by Virtus ETF Advisers LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
PCVX overviewAll 13F holders of PCVXFull Q2 2026 holdings
- Shares (Q2 2026)
- 0
- Sold out in Q2 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 13
- Since Q2 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 0 | $0 | 0.0% | −3,500−100.0% | Sold out | Holders |
| Q1 2026 | 3,500 | $203.4K | 0.1% | 00.0% | Unchanged | Holders |
| Q4 2025 | 3,500 | $161.5K | 0.1% | +3,500 | New | Holders |
| Q1 2025 | 0 | $0 | 0.0% | −809−100.0% | Sold out | Holders |
| Q4 2024 | 809 | $66.2K | <0.1% | −435−35.0% | Reduced | Holders |
| Q3 2024 | 1,244 | $142.2K | 0.1% | +21+1.7% | Added | Holders |
| Q2 2024 | 1,223 | $92.3K | <0.1% | −209−14.6% | Reduced | Holders |
| Q1 2024 | 1,432 | $97.8K | 0.1% | −96−6.3% | Reduced | Holders |
| Q4 2023 | 1,528 | $96.0K | 0.1% | −355−18.9% | Reduced | Holders |
| Q3 2023 | 1,883 | $96.0K | 0.1% | −192−9.3% | Reduced | Holders |
| Q2 2023 | 2,075 | $103.6K | 0.1% | −136−6.2% | Reduced | Holders |
| Q1 2023 | 2,211 | $82.9K | <0.1% | −853−27.8% | Reduced | Holders |
| Q4 2022 | 3,064 | $146.9K | 0.1% | −2,846−48.2% | Reduced | Holders |
| Q3 2022 | 5,910 | $142.0K | 0.1% | +45+0.8% | Added | Holders |
| Q2 2022 | 5,865 | $128.0K | <0.1% | +5,865 | New | Holders |